Form 4: ICU Medical President Sells Shares

ICU Medical President Daniel Woolson sold 2,123 shares of common stock on May 22, 2026.

Summary

• Daniel Woolson, President of ICU Medical, Inc., executed a sale of 2,123 shares of common stock.
• The shares were sold at a weighted average price of $132.2114 per share.
• Following the transaction, the reporting person retains beneficial ownership of 22,479 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it is a standard regulatory disclosure of an insider transaction without accompanying negative operational news.

Positives

• The transaction represents a routine divestment by an executive rather than a complete exit from equity ownership.

Negatives

• Insider selling can sometimes be perceived by the market as a lack of confidence in near-term stock price appreciation.

Risks

• Market volatility affecting the share price of ICUI.

Future Outlook

No forward-looking guidance or strategic outlook was provided in this filing.

Industry Context

StockSavvy.ai notes that executive stock sales are common occurrences for liquidity or tax planning purposes and do not necessarily reflect a change in the company's fundamental business outlook.

Comparison to Industry Standards

• The sale of shares by a President is a standard corporate governance event and is consistent with typical executive compensation and liquidity management practices across the medical device sector.

Stakeholder Impact

• Minimal impact expected on shareholders as this is a routine disclosure of executive equity movement.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

ICUI, ICU Medical, Insider Trading, Form 4, Stock Sale